
About Neuland Health Sciences Private Limited
Data last updated:
Neuland Health Sciences Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 31 March 1993.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG1993PTC015554. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹18.5 Cr and a paid-up capital of ₹12.43 Cr. It was led by directors including Ramamohan Davuluri Rao and Saharsh Rao Davuluri.
Its last annual general meeting (AGM) was held on 28 December 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Sanali Info Park 'A' Block Ground Floor 8 – 2 – 120/113 Road No. 2 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.19 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹26.69 Cr and EBITDA of ₹106.36 Cr.
The company had about 39 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 4 subsidiaries.
The company was associated with 2 brands: Neuland Health Sciences and Neuland Labs. As per MCA filings, the company had satisfied charges of ₹153.4 Cr on record. The company has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.7 Cr; the latest was in May 2017.
The last known website on record is neulandlabs.com.
Company details
CIN history
Neuland Health Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100TG1993PTC015554, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG1993PTC015554 | Current |
| U67120AP1993PTC015554 | Previous |
| U73100AP1993PTC015554 | Previous |
Contact details
Neuland Health Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is neulandlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSanali Info Park 'A' Block Ground Floor 8 – 2 – 120/113 Road No. 2 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, API Manufacturers
To see the full contact details of Neuland Health Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Neuland Health Sciences operates two associated brands: Neuland Health Sciences and Neuland Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients and peptides are manufactured globally. | neulandlabs.com | |
| Active pharmaceutical ingredients are manufactured by the company. | neulandhealthsciences.com |
Business activity
The main business activity of Neuland Health Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Neuland Health Sciences Private Limited, buy the company report.
Financials of Neuland Health Sciences Private Limited
FY 2017 filings availableNeuland Health Sciences Private Limited reported revenue of ₹3.19 Cr (up 10% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year. EBITDA rose 23% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹3.19 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹106.36 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹26.69 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Neuland Health Sciences Private Limited, buy the company report.
Board of directors of Neuland Health Sciences Private Limited
Neuland Health Sciences has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramamohan Davuluri Rao Also directs: Neuland Laboratories Ltd., Pattancheru Enviro-Tech Limited | Director | 16 Apr 2012 | 14 Years 7 Months | As last reported |
| Saharsh Rao Davuluri Also directs: Neuland Laboratories Ltd. | Director | 14 Oct 1999 | 27 Years 1 Months | As last reported |
| Sucheth Rao Davuluri | Director | 07 Mar 1997 | 29 Years 8 Months | As last reported |
| Sumeet Nagar Also directs: Malabar Fund Managers LLP, Brickstreet Homes LLP, Darjeeling Capital Managers LLP and 5 more | Additional Director | 23 Jun 2017 | 9 Years 4 Months | As last reported |
Auditor
Neuland Health Sciences Private Limited is audited by Walker, Chandiok & Co LLP for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker, Chandiok & Co LLP | FY 2017 | N500013 |
Shareholding
The shareholding of Neuland Health Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Neuland Health Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jan 2005 | 90136895 | State Bank of India | ₹150.9 Cr | Satisfied | |
| 29 Jan 2001 | 90139296 | Canbank Factors Limited | ₹2.5 Cr | Satisfied |
To see the full charge records of Neuland Health Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Neuland Health Sciences Private Limited has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.7 Cr; the latest was in May 2017.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2017 | Secondary share transfer | Undisclosed | Buyer: Steadview Capital, Malabar Funds, an individual Seller: InvAscent |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Malabar Investments Seller: an individual |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Dec 2012 | Funding round | ₹32 Cr | Investors: InvAscent |
| Nov 2012 | Funding round | ₹2.7 Cr | Investors: 4 individuals |
To see the full deal history of Neuland Health Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Neuland Health Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neuland Health Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Neuland Health Sciences has 4 subsidiary companies. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Neuland Laboratories Limited | L85195TG1984PLC004393 | |
| Neuland Laboratories Ltd | L85195TG1984PLC004393 | |
| Neuland Pharma Research Private Limited | U73100TG2012PTC080474 | |
| Neuland Pharma Research Private Limited | U73100TG2012PTC080474 |
To see the full group structure of Neuland Health Sciences Private Limited, buy the company report.
Employees & EPFO
Neuland Health Sciences Private Limited has a workforce of 39 employees on its EPFO records as of Mar 2018.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2017-18 | 39 |
| FY 2016-17 |
To see the full employee and EPFO history of Neuland Health Sciences Private Limited, buy the company report.
GST
Neuland Health Sciences has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Neuland Health Sciences Private Limited, buy the company report.
Recent activity
Neuland Health Sciences Private Limited has 8 board changes on record since 1997: 4 appointments and 4 cessations. The latest: Sumeet Nagar was appointed as Additional Director on 23 Jun 2017.
4 earlier events are in the company report.
News
Frequently asked questions
Neuland Health Sciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Neuland Health Sciences was a private limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 31 March 1993 and is registered under CIN U73100TG1993PTC015554. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Neuland Health Sciences was incorporated on 31 March 1993. It is registered with the Registrar of Companies, Hyderabad.
Neuland Health Sciences had 4 directors:
- Ramamohan Davuluri Rao - Director
- Saharsh Rao Davuluri - Director
- Sucheth Rao Davuluri - Director
- Sumeet Nagar - Additional Director
The CIN (Corporate Identification Number) of Neuland Health Sciences is U73100TG1993PTC015554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Neuland Health Sciences is at Sanali Info Park A Block Ground Floor 8 – 2 – 120113 Road No. 2 Banjara Hills, Hyderabad, Telangana, India – 500034.
Neuland Health Sciences can be reached through the website neulandlabs.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Neuland Health Sciences on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 28 December 2017. Year-wise statements from 2015 are in the company report.
No. Neuland Health Sciences has 3 GST registrations on record and all of them are cancelled or inactive.
Neuland Health Sciences operated in the pharma industry, in the api manufacturers segment.

